株式会社極東書店トップ商品一覧Mapping the Progress of Alzheimer's and Parkinson's Disease. Softcover reprint of the original 1st ed. 2002

商品詳細

Mapping the Progress of Alzheimer's and Parkinson's Disease. Softcover reprint of the original 1st ed. 2002

Mapping the Progress of Alzheimer's and Parkinson's Disease. Softcover reprint of the original 1st ed. 2002

・ISBN 978-1-4757-0973-5 paper EUR 199.99

¥53,456.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り
著者・編者Mizuno, Yoshikuni / Fisher, Abraham / Hanin, Israel (eds.),
シリーズ (Advances in Behavioral Biology)
出版社 (Springer-Verlag New York Inc., US)
出版年月2012
ページ数566 pp.
言語ENG
ニュース番号<A04-78707>

解説

1h The 5 International Conference on the Progress in Alzheimer's Disease and Parkinson's 51 1 Disease took place from March 31 to April 5 \ 2001 in Kroto, Japan. This international 1 conference was organized as a joint Congress with the 9 International Catecholamine Symposium. A total of 1258 clinicians and researchers participated in this joint congress 1h from 38 countries in the world. This book represents the proceedings of the 5 Conference on Alzheimer's and Parkinson's disease. The International Conference on the Progress in Alzheimer's and Parkinson's disease was first launched by Professor Abraham Fisher of Israel and Professor Israel Hanin of USA. The first conference was held in Eilat, Israel in 1985. The second conference was organized in Kyoto, Japan in 1989; the third one in Chicago, USA, in 1993, and the fourth one in Eilat, Israel in 1997. The International Catecholamine Symposium (ICS) is an international meeting devoted to the development of basic as well as clinical research on catecholamines. The first Catecholamine Symposium was held in Bethesda, USA in 1958. Since then this symposium has occurred every 5 years. Professor Toshiharu Nagatsu was appointed as 1h the president of the 9 International Catecholamine Symposium, which was to be held in 200 I also in Japan. Therefore, we decided to organize a joint congress of the two meetings, because there is much overlap in research between Alzheimer's disease, Parkinson's disease, and catecholamines. We thank Professor Nagatsu very much for agreeing to organizing this joint congress.